University of Iowa Assistant Professor, Department of Urology
Dr. Erickson is an Assistant Professor at the University of Iowa. He received his M.D. at the University of Iowa, a urology residency at Northwestern University and a fellowship in Genitourinary Trauma and Reconstruction at the University of California-San Francisco. He earned a Master’s of Science in Health Services Research at the University of Iowa in 2012.
Dr. Erickson’s clinical interests include male lower urinary tract dysfunction, urethral stricture disease, male urinary incontinence, urinary diversion, Peyronie’s disease, male genital reconstruction and neurogenic bladder including the long-term bladder management of people with spina bifida or spinal cord injury.
Dr. Erickson is board certified in urology and a member of the American Urologic Association. He is a fellow of the American College of Surgeons. He is a member of Genitourinary Reconstructive Surgeons, the leading academic and clinical forum for reconstructive urology.
Dr. Erickson is a founding member of the Trauma and Urinary Reconstructive Network of Surgeons (TURNS). University of Iowa is one of 8 centers that collaborate in the study of patients treated for a variety of conditions in trauma and reconstructive urology. This network is designed to collect centralized data and provide sophisticated analysis of both surgical and patient reported outcomes from urethral stricture surgery, male incontinence and a variety of other conditions. This type of collaborative research effort is essential to moving forward outcome research that is increasingly important in modern medicine.
Dr. Erickson is an active member of the urologic surgery outcomes research group at the University of Iowa and he is currently a co-investigator in two large National Institutes of Health collaborative studies: the Multiinstitutional Approach to Pelvic Pain (MAPP) and the Lower Urinary Tract Dysfunction Research Network (LURN). His main research interests include improving urologic health care delivery and comparing the effectiveness and costs for treatments of benign urologic conditions.